The purpose of this article is to review the literature and update analyses pertaining to the aggressiveness of cancer care near the end of life. Specifically, we will discuss trends and factors responsible for chemotherapy overuse very near death and underutilization of hospice services. Whether the concept of overly aggressive treatment represents a quality-of-care issue that is acceptable to all involved stakeholders is an open question. PMC ID: PMC2654813 (August 10, 2008)
Journal of Clinical Oncology
2008
Earle CC, Landrum MB, Souza JM, et al.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654813/